Stabilization of endogenous Nrf2 by minocycline protects against Nlrp3-inflammasome induced diabetic nephropathy
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Stabilization of endogenous Nrf2 by minocycline protects against Nlrp3-inflammasome induced diabetic nephropathy
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-10-10
DOI
10.1038/srep34228
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Select Cellular Stress Pathways to Prevent Hyperglycemia-Related Complications: Shifting the Paradigm
- (2016) Arshag D. Mooradian DRUGS
- Three-dimensional podocyte–endothelial cell co-cultures: Assembly, validation, and application to drug testing and intercellular signaling studies
- (2016) Min Li et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Caspase-1, but Not Caspase-3, Promotes Diabetic Nephropathy
- (2016) K. Shahzad et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effects of Minocycline on Urine Albumin, Interleukin-6, and Osteoprotegerin in Patients with Diabetic Nephropathy: A Randomized Controlled Pilot Trial
- (2016) Anuja P. Shah et al. PLoS One
- Notch1 and Notch2 in Podocytes Play Differential Roles During Diabetic Nephropathy Development
- (2015) Mariya T. Sweetwyne et al. DIABETES
- Improved renal function in diabetic patients with acute gout treated with anakinra
- (2015) Gowrie Balasubramaniam et al. KIDNEY INTERNATIONAL
- Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy
- (2015) Khurrum Shahzad et al. KIDNEY INTERNATIONAL
- Key pathways in renal disease progression of experimental diabetes: Figure 1:
- (2015) Carlamaria Zoja et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Nrf2 activators modulate oxidative stress responses and bioenergetic profiles of human retinal epithelial cells cultured in normal or high glucose conditions
- (2015) Roberta Foresti et al. PHARMACOLOGICAL RESEARCH
- Defective podocyte insulin signalling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy
- (2015) Thati Madhusudhan et al. Nature Communications
- The Concept and the Epidemiology of Diabetic Nephropathy Have Changed in Recent Years
- (2015) Alberto Martínez-Castelao et al. Journal of Clinical Medicine
- Molecular mechanisms of diabetic kidney disease
- (2014) Kimberly Reidy et al. JOURNAL OF CLINICAL INVESTIGATION
- Effect of Redox Modulating NRF2 Activators on Chronic Kidney Disease
- (2014) Bo-hyun Choi et al. MOLECULES
- Minocycline improves peripheral and autonomic neuropathy in type 2 diabetes: MIND study
- (2014) Ashit Syngle et al. NEUROLOGICAL SCIENCES
- Role of Nrf2 in Oxidative Stress and Toxicity
- (2013) Qiang Ma Annual Review of Pharmacology and Toxicology
- Minocycline: far beyond an antibiotic
- (2013) N Garrido-Mesa et al. BRITISH JOURNAL OF PHARMACOLOGY
- Defective Nrf2-dependent redox signalling contributes to microvascular dysfunction in type 2 diabetes
- (2013) Gopal V. Velmurugan et al. CARDIOVASCULAR RESEARCH
- Regulation of Nrf2—an update
- (2013) Suryakant K. Niture et al. FREE RADICAL BIOLOGY AND MEDICINE
- Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease
- (2013) Stacey Ruiz et al. KIDNEY INTERNATIONAL
- Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for hypoxic preconditioning-mediated delayed cardioprotection
- (2013) Xiao-Shan Huang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
- (2013) Dick de Zeeuw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms of Diabetic Complications
- (2013) Josephine M. Forbes et al. PHYSIOLOGICAL REVIEWS
- Toward clinical application of the Keap1–Nrf2 pathway
- (2013) Takafumi Suzuki et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Crosstalk between Nrf2 and the proteasome: Therapeutic potential of Nrf2 inducers in vascular disease and aging
- (2012) Sarah J. Chapple et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Regulation of intracellular signalling through cysteine oxidation by reactive oxygen species
- (2012) H. Miki et al. JOURNAL OF BIOCHEMISTRY
- Exogenous activated protein C inhibits the progression of diabetic nephropathy
- (2012) P. GIL-BERNABE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc
- (2012) F. Bock et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of Bardoxolone Methyl on Kidney Function in Patients with T2D and Stage 3b–4 CKD
- (2011) Pablo E. Pergola et al. AMERICAN JOURNAL OF NEPHROLOGY
- Minocycline reduces plaque size in diet induced atherosclerosis via p27Kip1
- (2011) Khurrum Shahzad et al. ATHEROSCLEROSIS
- Mouse models of diabetic nephropathy
- (2011) Charles E Alpers et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
- (2011) Hongting Zheng et al. DIABETES
- Diabetic Downregulation of Nrf2 Activity via ERK Contributes to Oxidative Stress-Induced Insulin Resistance in Cardiac Cells In Vitro and In Vivo
- (2011) Y. Tan et al. DIABETES
- Src Subfamily Kinases Regulate Nuclear Export and Degradation of Transcription Factor Nrf2 to Switch Off Nrf2-mediated Antioxidant Activation of Cytoprotective Gene Expression
- (2011) Suryakant K. Niture et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Inflammasomes in Kidney Disease
- (2011) H.-J. Anders et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Prevention of diabetic nephropathy in rats through enhanced renal antioxidative capacity by inhibition of the proteasome
- (2011) Zhi-Feng Luo et al. LIFE SCIENCES
- Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
- (2011) Pablo E. Pergola et al. NEW ENGLAND JOURNAL OF MEDICINE
- Minocycline with Aspirin: An Approach to Attenuate Diabetic Nephropathy in Rats
- (2011) Lokesh Kumar Bhatt et al. RENAL FAILURE
- When NRF2 Talks, Who's Listening?
- (2010) Nobunao Wakabayashi et al. ANTIOXIDANTS & REDOX SIGNALING
- The Protective Role of Nrf2 in Streptozotocin-Induced Diabetic Nephropathy
- (2010) T. Jiang et al. DIABETES
- A role for mitochondria in NLRP3 inflammasome activation
- (2010) Rongbin Zhou et al. NATURE
- eNOS Knockout Mice with Advanced Diabetic Nephropathy Have Less Benefit from Renin-Angiotensin Blockade than from Aldosterone Receptor Antagonists
- (2009) Tomoki Kosugi et al. AMERICAN JOURNAL OF PATHOLOGY
- Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling
- (2009) L. Gao et al. CARDIOVASCULAR RESEARCH
- Reactive species and diabetes: counteracting oxidative stress to improve health
- (2009) Patricia Pérez-Matute et al. CURRENT OPINION IN PHARMACOLOGY
- Mouse Models of Diabetic Nephropathy
- (2009) F. C. Brosius et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Thioredoxin-interacting protein links oxidative stress to inflammasome activation
- (2009) Rongbin Zhou et al. NATURE IMMUNOLOGY
- Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes
- (2008) J. M. Forbes et al. DIABETES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started